C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2006
11/16/2006	CA2607874A1 Quinoline derivatives as neurokinin receptor antagonists
11/16/2006	CA2607858A1 Affinity adsorbents for factor viii and von willebrand's factor
11/16/2006	CA2607670A1 Bicyclic derivatives as modulators of ion channels
11/15/2006	EP1720874A1 4-substituted piperidine derivatives
11/15/2006	EP1720868A1 Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain
11/15/2006	EP1720863A2 Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
11/15/2006	EP1720862A1 Kinase inhibitors
11/15/2006	EP1720861A2 Histamine h3 receptor antagonists, preparation and therapeutic uses
11/15/2006	EP1720847A1 Histamine-3 receptor modulators
11/15/2006	EP1720839A1 Pyridazinones as antagonists of a4 integrins
11/15/2006	EP1720836A1 6-substituted 2,3,4,5-tetrahydro-1h-benzo [d]azepines as 5-ht2c receptor agonists
11/15/2006	EP1720545A1 Bicyclic and bridged nitrogen heterocycles
11/15/2006	EP1720544A1 Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same
11/15/2006	EP1511482B1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
11/15/2006	EP1423121B1 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
11/15/2006	EP1411881B9 5ht2c receptor modulators
11/15/2006	EP1323711B1 Novel phenylalanine derivatives
11/15/2006	EP0968206B1 N-heterocyclic derivatives as nos inhibitors
11/15/2006	CN1863797A Cyclic amine BACE-1 inhibitors having a benzamide substituent
11/15/2006	CN1863796A Salts and polymorphs of a pyrrole-substituted indolinone compound
11/15/2006	CN1863794A Quinazoline derivatives as angiogenesis inhibitors
11/15/2006	CN1863782A 2-(quinoxalin-5-ylsulfonylamino)-benzamide compounds as cck2 modulators
11/15/2006	CN1863781A 2-(quinoxalin-5-ylsulfonylamino)-benzamide compounds as cck2 modulators
11/15/2006	CN1863780A Protein kinase inhibitors and uses thereof
11/15/2006	CN1863778A Compounds and methods for treating dyslipidemia
11/15/2006	CN1863771A Sequence selective pyrrole and imidazole polyamide metallocomplexes
11/15/2006	CN1863770A Cyclic amine BASE-1 inhibitors having a heterocyclic substituent
11/15/2006	CN1863768A 8-aza-11-deoxy prostaglandin analogues
11/15/2006	CN1863534A Quinazoline derivatives as inhibitors of vegf receptor tyrosine kinases
11/15/2006	CN1863528A Indoles and azaindoles as antiviral agents
11/15/2006	CN1861567A Triarylamine-based compound for organic electroluminescent device and organic electroluminescent device employing the same
11/15/2006	CN1284777C 5-membered heterocycles, preparation and use thereof as medicine
11/14/2006	US7135575 P38 inhibitors and methods of use thereof
11/14/2006	US7135495 Indole derivatives
11/14/2006	US7135491 5-Aryltetrazole compounds and uses thereof
11/14/2006	US7135490 Method for the treatment of glomerulonephritis
11/14/2006	US7135488 Pyrrolyl-thiazole derivatives
11/14/2006	US7135484 Azabicyclic compounds are central nervous system active agents
11/14/2006	US7135477 Administering N-(2-[N',N'-diethylamino]-5-[N''-(4-fluorophenylsulfonyl)-N''-propargylamino]pyrimidin-4-yl)-4'-(pyrrolidin-1-ylcarbonyloxy)-L-phenylalanine as an antiinflammatory agent treating rheumatoid arthritis
11/14/2006	US7135476 Corticotropin releasing factor antagonists; anxiolytic agents; (2,3,5',6',-Tetrahydro)-2'-methyl-4'-(N-propyl-N-cylopropylmethyl-amino) spiro[(1H)indene-1,8'-(7H)quinazoline]; (2,3,5',6',-Tetrahydro)-2'-methyl-4'-(N-propyl-N-cylopropylmethyl-amino) spiro[(1H)indene-1,7'-(5H)cyclopentapyrimidine]
11/14/2006	US7135473 Cyclic diamine compound with condensed-ring groups
11/14/2006	US7135471 Aryl oximes
11/14/2006	US7135467 HIV integrase inhibitors
11/14/2006	US7135466 used in the treatment of diseases mediated by the autophosphorylation of a PDGF receptor, specifically, compounds which can inhibit neointima formation hypertrophy.
11/14/2006	CA2379572C Polymorphic salt
11/14/2006	CA2274669C 1,5-benzodiazepine derivatives
11/14/2006	CA2244363C Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains
11/09/2006	WO2006119451A1 Pyrimidines and pyrazines useful as modulators of ion channels
11/09/2006	WO2006119148A2 Keratinocyte growth factor receptor - tyrosine specific inhibitors for the prevention of cancer metastatis
11/09/2006	WO2006118256A1 2-aminoquinazoline derivatives
11/09/2006	WO2006117760A1 Adrenergic receptor antagonists
11/09/2006	WO2006117560A1 Pyrazolyl-amino- substituted pyrimidines and their use in the treatment of cancer
11/09/2006	WO2006117552A1 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity
11/09/2006	WO2006117523A1 Quinazoline derivatives as egf and/or erbb2 tyrosine kinase inhibitors
11/09/2006	WO2006015191A3 Multicyclic lonidamine analogs
11/09/2006	WO2005079802A8 Bipyridyl amides as modulators of metabotropic glutamate receptor-5
11/09/2006	US20060252943 Chemical process
11/09/2006	US20060252942 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-YL)methyl]-4H-carbazol-4-one
11/09/2006	US20060252939 Preparation of candesartan cilexetil
11/09/2006	US20060252931 New CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
11/09/2006	US20060252810 e.g. 5-(4-Fluorophenyl)-4-(4-pyridinyl)imidazole-2-thio-3-propyl-N-phthalimide; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent
11/09/2006	US20060252793 Useful as adjuvants to chemotherapy or radiation therapy to treat cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2); 2-[4-(3,4-dichloro-phenoxy)-phenyl]-1H-imidazo[4,5-b]pyridine-5-carboxylic acid amide
11/09/2006	US20060252778 Compounds for the treatment of inflammatory disorders
11/09/2006	US20060252777 5-[4-(6,7-Dimethoxy-quinolin-4-yloxy)-3-fluoro-phenyl]-2-(4-fluoro-phenylamino)-3-methyl-3H-pyrimidin-4-one; anticarcinogenics, antimetastasis agents, antiproliferatives, angiogenesis inhibitors; hepatocyte growth factor mediated diseases
11/09/2006	US20060252772 Novel crystalline forms of gatifloxacin and processes for preparation
11/09/2006	US20060252771 Novel crystalline forms of gatifloxacin and processes for preparation
11/09/2006	US20060252770 Novel crystalline forms of gatifloxacin and processes for preparation
11/09/2006	US20060252769 Obesity, type 2 diabetes, sleep disorders, ischaemic or haemorrhagic strokes, antiemetic; toxicity; side effect reduction; 2-((benzofuran-4-yl)carbonylaminomethyl)-1-((4-(5-(4-fluorophenyl)-2-methyl)thiazolyl)carbonyl)-4-methylpiperazine
11/09/2006	US20060252768 2,3,6-Trisubstituted-4-pyrimidone derivatives
11/09/2006	US20060252767 Piperazine derivatives and their use as therapeutic agents
11/09/2006	US20060252766 Methods using a combination of 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia
11/09/2006	US20060252764 HIV inhibiting pyrimidines derivatives
11/09/2006	US20060252755 E.g., 3-(3-benzylphenyl)-1-(2,2,2-trifluoroethyl)-4,5-dihydro-1,2,4-triazin-6(1H)-one and 3-{3-[(Z)-(Methoxyimino)phenyl)methyl]phenyl}-1-(2,2,2-trifluoroethyl)-4,5-dihydro-1,2,4-triazin-6(1H)-one; broad spectrum
11/09/2006	US20060252752 Octahydrocyclopenta[b]pyrrole-sulfonamide-2-carboxylic acid derivatives; reduced side effects
11/09/2006	US20060252751 specific compound N-(2-{[(3R)-1-(4-hydroxy-4-pyrimidin-4-ylcyclohexyl)pyrrolidin-3-yl]amino}-2-oxoethyl)-3-(trifluoromethyl)benzamide; multiple sclerosis; CCR2 and/or CCR5 antagonists
11/09/2006	US20060252750 1-(3,4-dibromo-benzyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate; calcitonin gene related peptide antagonist; analgesic, antidiabetic agent; migraine or cluster headaches, non-insulin-dependent diabetes
11/09/2006	US20060252747 Substitituted 1-piperidin-3-yl-piperidin 4-yl-piperazine derivatives and their use as neurokinin auantagonists
11/09/2006	US20060252679 Preventive and/or trerapeutic drgs for itch
11/09/2006	US20060252673 Synergistic combinations with morphine; analgesics and cyclooxygenase-2 inhibitors, such as N-5-guanidinopentanamide-(2S)-yl-2-N-(p-hydroxyphenylacetyl)phenylenediamine and N-5-guanidinopentanamide-(2R)-yl-2-N-(p-hydroxybenzyl)-5-carboxybenzimidazole
11/09/2006	DE102005019712A1 Dipyridyl-dihydropyrazolone und ihre Verwendung Dipyridyl dihydropyrazolones and their use
11/09/2006	CA2606338A1 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity
11/09/2006	CA2603818A1 Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles
11/09/2006	CA2600052A1 Benzotriazole derivatives as cannabinoid receptor antagonists
11/08/2006	EP1719777A1 Electrochemically active ligand for sequence-specific detection of double-stranded nucleic acid molecule
11/08/2006	EP1719763A1 Novel pyridine derivative and pyrimidine derivative (2)
11/08/2006	EP1719762A1 Novel pyridine derivative and pyrimidine derivative (1)
11/08/2006	EP1719761A1 Novel heterocyclic compound
11/08/2006	EP1718625A1 Compounds
11/08/2006	EP1718624A1 Benzamide derivatives and their use as glucokinase activating agents
11/08/2006	EP1718611A1 3-3-di-substituted-oxindoles as inhibitors of translation initiation
11/08/2006	EP1718608A1 Viral polymerase inhibitors
11/08/2006	EP1718307A2 Immunosuppressant compounds and compositions
11/08/2006	EP1718305A1 Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides
11/08/2006	EP1429761B1 Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
11/08/2006	EP1080074B1 Heterocyclic substituted amides, their production and their use
11/08/2006	EP1021190B1 Amid derivatives as growth hormone release promotors
11/08/2006	CN1860106A Compounds and compositions as protein kinase inhibitors
11/08/2006	CN1860104A 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors
11/08/2006	CN1860097A Amide type carboxamide derivative
11/08/2006	CN1859912A Inhibitors of Akt activity

1 ... 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 ... 626